Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021346

CHIEF MEDICAL OFFICER sold 29,325 shares at $32.55 ($954,529)

  • CHIEF MEDICAL OFFICER acquired 29,325 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Paolini John F. CHIEF MEDICAL OFFICER 2025-08-06 Option exercise 10b5-1 +29,325 $3.80 $111,435 86,728 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-08-06 Sale 10b5-1 −29,325 $32.55 $954,529 57,403 D
Derivatives
Paolini John F. CHIEF MEDICAL OFFICER 2025-08-06 Option exercise · Share Option 10b5-1 −29,325 36,542 D
Open-market sales · 29,325 sh · avg $32.55 · $954,529
Loading xslF345X05/form4-08082025_040802.xml…